* Privia Health Group Inc PRVA.OQ PRVA.O is expected
to show a
rise in quarterly revenue when it reports results on February
27 for the period ending December 31 2023
* The Arlington Virginia-based company is expected to
report a
15.1% increase in revenue to $730.892 million from $634.8
million a year ago, according to the mean estimate from 8
analysts, based on LSEG data. (Revenue consensus is on Total
practice collection(non- gaap))
* LSEG's mean analyst estimate for Privia Health Group Inc
is for
earnings of 4 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 17 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Privia
Health
Group Inc is $31.00, above its last closing price of $19.80.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 0.05 0.05 0.05 Met 0
Jun. 30 2023 0.06 0.06 0.06 Met 7.4
Mar. 31 2023 0.03 0.02 0.06 Beat 228.8
Dec. 31 2022 -0.03 -0.03 0.14 Beat 606.5
Sep. 0.00 0.00 0.01 Beat 109.2
30 2022
Jun. 30 2022 -0.02 -0.03 0.14 Beat 636.2
Mar. 31 2022 -0.05 -0.04 -0.16 Missed -340.4
Dec. 31 2021 -0.18 -0.13 -0.11 Beat 17.7
This summary was machine generated February 23 at 13:55 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)